The business case for cell and gene therapies

Mohamed Abou-El-Enein, Gerhard Bauer, Petra Reinke

Research output: Contribution to journalArticle

14 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1192-1193
Number of pages2
JournalNature Biotechnology
Volume32
Issue number12
DOIs
StatePublished - Dec 1 2014

Fingerprint

Gene therapy
Cost benefit analysis
Cell- and Tissue-Based Therapy
Genetic Therapy
Cost-Benefit Analysis
Industry

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Biotechnology
  • Molecular Medicine
  • Bioengineering
  • Biomedical Engineering

Cite this

The business case for cell and gene therapies. / Abou-El-Enein, Mohamed; Bauer, Gerhard; Reinke, Petra.

In: Nature Biotechnology, Vol. 32, No. 12, 01.12.2014, p. 1192-1193.

Research output: Contribution to journalArticle

Abou-El-Enein, M, Bauer, G & Reinke, P 2014, 'The business case for cell and gene therapies', Nature Biotechnology, vol. 32, no. 12, pp. 1192-1193. https://doi.org/10.1038/nbt.3084
Abou-El-Enein, Mohamed ; Bauer, Gerhard ; Reinke, Petra. / The business case for cell and gene therapies. In: Nature Biotechnology. 2014 ; Vol. 32, No. 12. pp. 1192-1193.
@article{3b13916f8e56449e96b97a3a1594f458,
title = "The business case for cell and gene therapies",
author = "Mohamed Abou-El-Enein and Gerhard Bauer and Petra Reinke",
year = "2014",
month = "12",
day = "1",
doi = "10.1038/nbt.3084",
language = "English (US)",
volume = "32",
pages = "1192--1193",
journal = "Biotechnology",
issn = "1087-0156",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - The business case for cell and gene therapies

AU - Abou-El-Enein, Mohamed

AU - Bauer, Gerhard

AU - Reinke, Petra

PY - 2014/12/1

Y1 - 2014/12/1

UR - http://www.scopus.com/inward/record.url?scp=84922188493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922188493&partnerID=8YFLogxK

U2 - 10.1038/nbt.3084

DO - 10.1038/nbt.3084

M3 - Article

C2 - 25489833

AN - SCOPUS:84922188493

VL - 32

SP - 1192

EP - 1193

JO - Biotechnology

JF - Biotechnology

SN - 1087-0156

IS - 12

ER -